These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19770796)

  • 1. Effect of ethanol on the release of morphine sulfate from Oramorph SR tablets.
    Barkin RL; Shirazi D; Kinzler E
    Am J Ther; 2009; 16(6):482-6. PubMed ID: 19770796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of a new sustained-release formulation of morphine.
    Araico A; Saadeddin A; Torres-Molina F; Peris JE
    Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules.
    Johnson F; Wagner G; Sun S; Stauffer J
    J Pain; 2008 Apr; 9(4):330-6. PubMed ID: 18201934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alcohol on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules.
    Johnson FK; Ciric S; Boudriau S; Kisicki J; Stauffer J
    J Clin Pharmacol; 2012 May; 52(5):747-56. PubMed ID: 21593282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol effects on drug release from Verapamil Meltrex, an innovative melt extruded formulation.
    Roth W; Setnik B; Zietsch M; Burst A; Breitenbach J; Sellers E; Brennan D
    Int J Pharm; 2009 Feb; 368(1-2):72-5. PubMed ID: 18992310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
    Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
    J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of AVINZA (morphine sulfate extended-release capsules) for chronic moderate-to-severe noncancer pain conducted under real-world treatment conditions--the ACCPT Study.
    Adams EH; Chwiecko P; Ace-Wagoner Y; Mangefrida B; Duerden ME; Perdikis GC; Kunkel FA; Ghalie R
    Pain Pract; 2006 Dec; 6(4):254-64. PubMed ID: 17129306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term rectal administration of high-dose sustained-release morphine tablets.
    Walsh D; Tropiano PS
    Support Care Cancer; 2002 Nov; 10(8):653-5. PubMed ID: 12436225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential cost-avoidance with oral extended-release morphine sulfate tablets versus morphine sulfate solution.
    Goughnour BR; Arkinstall WW
    Am J Hosp Pharm; 1991 Jan; 48(1):101-4. PubMed ID: 2000864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW; Goughnour BR; White JA; Stewart JH
    CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two doses of oral sustained-release tramadol do not reduce pain or morphine consumption after modified radical mastectomy: a randomized, double blind, placebo-controlled trial.
    Thienthong S; Krisanaprakornkit W; Taesiri W; Thaninsurat N; Utsahapanich S; Klaichanad C
    J Med Assoc Thai; 2004 Jan; 87(1):24-32. PubMed ID: 14971531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
    Gourlay GK
    Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution of oral modified-release tablets and capsules in ethanolic media.
    Smith AP; Moore TW; Westenberger BJ; Doub WH
    Int J Pharm; 2010 Oct; 398(1-2):93-6. PubMed ID: 20667505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetic profiles of two oral controlled-release morphine formulations in healthy young adults.
    Hunt TL; Kaiko RF
    Clin Ther; 1991; 13(4):482-8. PubMed ID: 1934000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of the in vitro drug release behaviour of oral modified release preparations in the presence of alcohol.
    Fadda HM; Mohamed MA; Basit AW
    Int J Pharm; 2008 Aug; 360(1-2):171-6. PubMed ID: 18547758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
    Lennernäs H
    Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.